AU1631997A - Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin - Google Patents

Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin

Info

Publication number
AU1631997A
AU1631997A AU16319/97A AU1631997A AU1631997A AU 1631997 A AU1631997 A AU 1631997A AU 16319/97 A AU16319/97 A AU 16319/97A AU 1631997 A AU1631997 A AU 1631997A AU 1631997 A AU1631997 A AU 1631997A
Authority
AU
Australia
Prior art keywords
aspirin
oligosaccharide
association
combination
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU16319/97A
Other versions
AU698456B2 (en
Inventor
Roger Cariou
Jacobus Stiekema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi SA
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002199642A priority Critical patent/CA2199642C/en
Priority to EA199700025A priority patent/EA000048B1/en
Application filed by Sanofi SA, Akzo Nobel NV filed Critical Sanofi SA
Priority to AU16319/97A priority patent/AU698456B2/en
Priority to BR9701313A priority patent/BR9701313A/en
Publication of AU1631997A publication Critical patent/AU1631997A/en
Application granted granted Critical
Publication of AU698456B2 publication Critical patent/AU698456B2/en
Assigned to SANOFI-SYNTHELABO, AKZO NOBEL N.V. reassignment SANOFI-SYNTHELABO Request to Amend Deed and Register Assignors: AKZO NOBEL N.V., SANOFI
Assigned to SANOFI-SYNTHELABO reassignment SANOFI-SYNTHELABO Alteration of Name(s) in Register under S187 Assignors: AKZO NOBEL N.V., SANOFI-SYNTHELABO
Assigned to SANOFI-AVENTIS reassignment SANOFI-AVENTIS Request to Amend Deed and Register Assignors: SANOFI-SYNTHELABO
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16319/97A 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin Expired AU698456B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (en) 1997-03-10 1997-03-10 Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
EA199700025A EA000048B1 (en) 1997-03-10 1997-03-13 Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of anti-xa oligosaccharide optionally in combination with aspirin
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (en) 1997-03-10 1997-03-17 Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (en) 1997-03-10 1997-03-10 Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (en) 1997-03-10 1997-03-17 Compositions containing an association of aspririn and an anti-xa oligosaccharide and use of an anti-xa olysaccharide optionally in combination with aspirin

Publications (2)

Publication Number Publication Date
AU1631997A true AU1631997A (en) 1998-09-17
AU698456B2 AU698456B2 (en) 1998-10-29

Family

ID=27152254

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16319/97A Expired AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin

Country Status (4)

Country Link
AU (1) AU698456B2 (en)
BR (1) BR9701313A (en)
CA (1) CA2199642C (en)
EA (1) EA000048B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1820A (en) * 2001-11-13 2008-01-11 Sanofi Synthelabo Use of specific dose of fondaparinux sodium for the treatment of ACS.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2564468B1 (en) * 1984-05-16 1994-12-23 Choay Sa NOVEL OLIGOSACCHARIDES, THEIR SYNTHESIS PREPARATION AND THEIR BIOLOGICAL APPLICATIONS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1820A (en) * 2001-11-13 2008-01-11 Sanofi Synthelabo Use of specific dose of fondaparinux sodium for the treatment of ACS.

Also Published As

Publication number Publication date
CA2199642C (en) 2001-05-08
BR9701313A (en) 1998-11-17
CA2199642A1 (en) 1998-09-10
EA000048B1 (en) 1998-04-30
EA199700025A1 (en) 1997-12-30
AU698456B2 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AU1583795A (en) Galactomannan products and compositions containing the same
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU7564694A (en) Erection-inducing methods and compositions
PL314956A1 (en) Siclicium-sodium-calcium glass compositions and their application
AU4266596A (en) Composition and use
AU3063597A (en) Polyalkylphenoxyaminoalkanes and fuel compositions containing the same
AU6959694A (en) Antineoplastic compositions and methods of use
AU9301998A (en) Composition and methods using galectin-1
GB9413090D0 (en) Benzazepine derivatives compositions containing them and their use in therapy
AU1631997A (en) Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
AU5774796A (en) Pharmaceutical compositions containing lornoxicam and cyclod extrin
AU6682498A (en) Phagocytosis activator compositions and their use
AU3383195A (en) Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol
AU7681498A (en) Pharmaceutical composition and use thereof
AUPO982097A0 (en) Methods and compositions for use therein
ZA981782B (en) The use of levobupivacaine in combination with other drugs
AU691690B2 (en) Acrolein-releasing composition and use thereof
AUPP775298A0 (en) Improvements in and relating to the construction of cabinets
AU4026897A (en) Substituted 2-cyclohexyl-propan-1-ol and its use in perfume compositions
AU5020693A (en) Aqueous organosiloxane liquid composition and its use
AU5405296A (en) Iso-alpha-acid formulation and its use
AU3171099A (en) 1-heteroindene derivatives and medicinal composition containing the same
AU6622196A (en) Composition and its use
GB9306456D0 (en) Composition and use
SI0748222T1 (en) Antitussive composition containing an antitussive and benzydamine

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: SANOFI-SYNTHELABO, AKZO NOBEL NV

Free format text: FORMER NAME WAS: SANOFI, AKZO NOBEL NV

PC Assignment registered

Owner name: SANOFI-SYNTHELABO

Free format text: FORMER OWNER WAS: SANOFI-SYNTHELABO, AKZO NOBEL NV